|Place of Origin:||CHINA|
|Model Number:||Antineoplastic Drugs API - 23|
|Minimum Order Quantity:||1KG|
|Packaging Details:||Aluminum foil bag,kraft paper bag|
|Delivery Time:||Within 7 days|
|Payment Terms:||L/C, T/T|
|Supply Ability:||Can be customized according to customer requirements|
|Molecular Weight:||371.25||Usage:||Pharmaceutical Grade Chemicals|
chemical raw materials,
pharmaceutical raw materials
Carboplatin CAS 41575-94-4 cbdca Pharmaceutical Grade Chemicals
Carboplatin is the second generation platinum antineoplastic drug. Its antineoplastic activity is similar to that of cisplatin. However, its nephrotoxicity, ototoxicity and neurotoxicity, especially gastrointestinal reaction, are significantly lower than that of cisplatin, and its antineoplastic spectrum is not as broad as that of cisplatin.
|Appearance||White crystalline powder||White crystalline powder|
|By IR spectrum||
Spectrum sample should be consistent
With spectrum of reference standard
And other impurity≤0.25%
|PH||5.0 ~ 7.0||6.0|
|Residual Solvents||Ethanol ≤500ppm||N.D|
|Water-insoluble matter||NMT 0.5%||0.30%|
|1,1-cyclobutanedicarboxylic acid||NMT 0.5%||N.D|
|Crystalline||Meets the requirements||Conforms|
Any individual impurity≤0.25%
The sum of all impurities≤0.5%
1. The second generation platinum complex antineoplastic drugs. The antitumor spectrum and activity are similar to that of cisplatin, but its water solubility is better than that of cisplatin, and its toxicity to kidney is also lower. For small cell lung cancer, ovarian cancer, head and neck squamous cell cancer, testicular tumors, malignant lymphoma and other good curative effect, in addition can also be used for cervical cancer, bladder cancer.
2. It is a new second generation platinum anticancer drug. Its activity is similar to that of cisplatin. Its biochemical properties and activity spectrum are similar, but its toxicity and side effects are lower than that of cisplatin.
We can customize according to customer's requirement.
If you have any question pls mail us or call us.